Valued at $413.1M at its later-stage round, Dec 2025. Nothing has traded since.
- ·Watch BlossomHill Therapeutics: the Monday email on marks, rounds and moves
Valuation timeline
0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026Membership and data by Private Market View
BlossomHill Therapeutics funding history
4 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Nov 2025 | Later Stage VC | $84.2M | ▮ | ▮ |
| Dec 2023 | Later Stage VC | $88.6M | ▮ | ▮ |
| Mar 2021 | Later Stage VC | $71.0M | ▮ | ▮ |
| Dec 2020 | Seed Round | $2.0M | ▮ | ▮ |
Membership and data by Private Market View
BlossomHill Therapeutics valuation
BlossomHill Therapeutics was valued at $413 million at its later-stage round in Dec 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.
How much has BlossomHill Therapeutics raised?
BlossomHill Therapeutics has raised $257 million across 4 recorded rounds since 2020. The largest was an $88.6 million later-stage round in Dec 2023; the most recent was an $84.2 million later-stage round in Nov 2025.
BlossomHill Therapeutics has filed 4 Form Ds with the SEC since 2021, most recently in Dec 2025 ($84.2 million sold to 47 investors).
How BlossomHill Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For BlossomHill Therapeutics, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →
Frequently asked about BlossomHill Therapeutics
- What is BlossomHill Therapeutics worth?
- BlossomHill Therapeutics is valued at $413.1M as of Oct 2026. Valued at $413.1M at its later-stage round, Dec 2025. Nothing has traded since.
- How much has BlossomHill Therapeutics raised?
- BlossomHill Therapeutics has raised $257.1M in total funding across 4 recorded rounds.
- When did BlossomHill Therapeutics last raise?
- BlossomHill Therapeutics last raised in Nov 2025 (Later Stage VC), raising $84.2M.